Skip to main content

Early Biochemical Effects of GM1 Ganglioside Treatment in Lesioned Brain: Dependence on Degree of Fiber Degeneration

  • Chapter
Gangliosides and Neuronal Plasticity

Part of the book series: FIDIA Research Series ((FIDIA,volume 6))

Abstract

Several reports show that ganglioside treatment, and especially GM1 ganglioside, facilitates various forms of long-term recovery following lesions of the brain (Agnati et al., 1984; Kojima et al., 1984; Oderfeld-Nowak et al., 1984a; b; Toffano et al., 1983; Toffano et al., 1984a; b; Wójcik et al., 1982). Enhanced recovery has been hypothesized to be due mainly to increased sprouting processes. Recently, however, several laboratories have also reported beneficial effects of GM1 treatment upon the impaired functions in an acute phase of CNS injury, (Fass and Ramirez, 1984; Karpiak and Mahadik, 1984; Sabel et al., 1984), and this fact, considering the time period, can hardly be ascribed to facilitation of sprouting. Therefore, other phenomena are probably involved. In fact, several authors pointed out some early compensatory biochemical effects of GM1 treatment after brain lesions. An increase in choline uptake in the cerebral cortex after lesion in the nucleus basalis magnocellularis (Pedata et al., 1984), an increase in dopamine uptake in the striatum following partial hemitransection (Toffano et al., 1984b), an increase of the lowered activity of Na+, K+-ATPase associated with edema (Karpiak and Mahadik, 1984; Karpiak et al., 1986), restoration of striatal energy metabolism (Fuxe et al., 1986), were reported. Hypotheses concerning the effect of ganglioside on increasing of the impulse flow, and/or enhancing biosynthetic processes (Pedata et al., 1984; Toffano et al., 1984b), and effects on restabilization of membrane properties (Janigro et al., 1984; Karpiak and Mahadik, 1984; Karpiak et al., 1986) have been advanced. We are now reporting data which indicate yet another early biochemical facilitatory effect of GM 1, namely, on post-lesion recovery of the hippocampal cholinergic and serotoninergic parameters.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Abbreviations

CNS:

central nervous system

i.m.:

intramuscular

AChE:

acetylcholine esterase

ChAT:

choline acetyltransferase

5-HT:

5-hydroxytriptamine

GM1:

monosialoganglioside

NGF:

nerve growth factor.

References

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Oderfeld-Nowak, B., Skup, M., Gradkowska, M., Kiedrowski, L. (1986). Early Biochemical Effects of GM1 Ganglioside Treatment in Lesioned Brain: Dependence on Degree of Fiber Degeneration. In: Tettamanti, G., Ledeen, R.W., Sandhoff, K., Nagai, Y., Toffano, G. (eds) Gangliosides and Neuronal Plasticity. FIDIA Research Series, vol 6. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-5309-7_34

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-5309-7_34

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-5311-0

  • Online ISBN: 978-1-4757-5309-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics